{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:04:15Z","timestamp":1761743055733},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T00:00:00Z","timestamp":1204502400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Nephrology"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p><jats:bold>Background:\u2003<\/jats:bold> Haemodialysis (HD) continues to carry the risk of hepatitis C virus (HCV) transmission, with delayed seroconversion and often normal alanine aminotransferase (ALT) values increasing the likelihood of undetected infection and thus uninterrupted spread of HCV. The aim of this study was to identify the characteristic patterns of ALT changes and seroconversion during an outbreak of HCV in a HD unit. We also wanted to establish the relationship between infecting viruses using molecular analysis.<\/jats:p><jats:p><jats:bold>Methods:\u2003<\/jats:bold> All patients (<jats:italic>n<\/jats:italic>\u2003=\u200372) and staff (<jats:italic>n<\/jats:italic>\u2003=\u200323) of the HD unit were prospectively followed for 14\u2003months. Serial measurements for ALT, HCV antibody and HCV\u2010RNA were performed besides HCV sequence analysis.<\/jats:p><jats:p><jats:bold>Results:\u2003<\/jats:bold> The initial screening for anti\u2010HCV and HCV\u2010RNA confirmed chronic infection in 16\/72 (22%) subjects and identified three subjects with recent seroconversion. In addition, five cases were reverse transcription\u2010polymerase chain reaction positive alone for a total of eight recent cases. The interval between the initial observation of ALT changes and seroconversion varied from 1 to 8\u2003months, and in several individuals ALT fluctuations only below the upper limit of normal were detected. However, relating each subject's ALT values to ALT at baseline, ALT levels increased between 1.6\u2010 and 4.7\u2010fold. Molecular analysis provided evidence for transmission from two chronically infected source patients, probably because of inappropriate infection control measures.<\/jats:p><jats:p><jats:bold>Conclusion:\u2003<\/jats:bold> Our data highlight the importance of well\u2010implemented safety precautions and regular HCV\u2010RNA testing to prevent the further spread of HCV in this population, and suggest the use of ALT baseline values to identify infections that may remain unnoticed otherwise.<\/jats:p>","DOI":"10.1111\/j.1440-1797.2008.00931.x","type":"journal-article","created":{"date-parts":[[2008,3,4]],"date-time":"2008-03-04T00:41:27Z","timestamp":1204591287000},"page":"186-192","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular analysis and patterns of ALT and hepatitis C virus seroconversion in haemodialysis patients with acute hepatitis"],"prefix":"10.1111","volume":"13","author":[{"given":"ELISABETH","family":"LAMPE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CLARA FUMIKO TACHIBANA","family":"YOSHIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROSANE VIEIRA","family":"DE OLIVEIRA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GEORG M","family":"LAUER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LIA LAURA","family":"LEWIS\u2010XIMENEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,3]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"crossref","unstructured":"FinelliL MillerJT TokarsJI AlterMJ ArduinoMJ.National surveillance of dialysis\u2010associated diseases in the United States 2005.Semin. Dial.2002;18:52\u201361.","DOI":"10.1111\/j.1525-139X.2005.18108.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","unstructured":"JadoulM.Epidemiology and mechanisms of transmission of the hepatitis C virus in haemodialysis.Nephrol. Dial. Transplant.2000;15(Suppl 8):39\u201341.","DOI":"10.1093\/ndt\/15.suppl_8.39"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","unstructured":"FissellRB Bragg\u2010GreshamJL WoodsJDet\u2003al.Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: The DOPPS.Kidney Int.2004;65:2335\u201342.","DOI":"10.1111\/j.1523-1755.2004.00649.x"},{"key":"e_1_2_7_5_2","unstructured":"Di LalloD MiceliM PetrosilloN PerucciCA MoscatelliM.Risk factors of hepatitis C virus infection in patient on haemodialysis: A multivariate analysis based on a dialysis register in Central Italy.Eur. J. Epidemiol.1999;15:11\u201314."},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","unstructured":"SimonN CourouceM LemarrecN TrepoC DucampS.A twelve\u2010year natural history of hepatitis C virus infection in haemodialyzed patients.Kidney Int.1994;46:504\u201311.","DOI":"10.1038\/ki.1994.301"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","unstructured":"OkudaK HayashiH KobayashiS IrieY.Mode of hepatitis C infection not associated with blood transfusion among chronic haemodialysis patients.J. Hepatol.1995;23:28\u201331.","DOI":"10.1016\/0168-8278(95)80307-6"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","unstructured":"GilliP MorettiM SoffrittiSet\u2003al.Non\u2010A non\u2010B hepatitis and anti\u2010HCV antibodies in dialysis patients.Int. J. Artif Organs.1990;13:737\u201341.","DOI":"10.1177\/039139889001301105"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","unstructured":"AllanderT MedinC JacobsonSH GrillnerL PerssonnMAA.Hepatitis C transmission in a haemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment.J. Med. Virol.1994;43:415\u201319.","DOI":"10.1002\/jmv.1890430417"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","unstructured":"AlbuquerqueACC CoelhoMRCD LopesEPA LemosMF MoreiraRC.Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife Brazil.Mem. Inst. Oswaldo Cruz2005;100:467\u201370.","DOI":"10.1590\/S0074-02762005000500003"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02762005000400002"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-7-32"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20932"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46651995000100012"},{"key":"e_1_2_7_15_2","unstructured":"Minist\u00e9rio da Sa\u00fade do Brasil.1996. Portaria N02042.Di\u00e1rio Oficial da Uni\u00e3o."},{"key":"e_1_2_7_16_2","first-page":"1","article-title":"Recommendations for preventing transmission of infectious among chronic hemodialysis patients","volume":"50","author":"CDC.","year":"2001","journal-title":"MMWR"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200104)63:4<265::AID-JMV1000>3.0.CO;2-V"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199709)53:1<36::AID-JMV7>3.0.CO;2-R"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/5.2.150"},{"key":"e_1_2_7_20_2","first-page":"151","article-title":"High ALT levels predict viremia in anti\u2010HCV\u2010positive HD patients if a modified normal range of ALT is applied","volume":"54","author":"Espinosa M","year":"2000","journal-title":"Clin. Nephrol."},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2005.09.010"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655902762467611"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.122"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190287"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52062.x"},{"key":"e_1_2_7_26_2","first-page":"611","article-title":"The susceptibility of patients with type\u20102 diabetes to hepatitis C virus infection during long\u2010term haemodialysis","volume":"133","author":"Saxena AK","year":"2003","journal-title":"Swiss Med. Wkly."}],"container-title":["Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1797.2008.00931.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1797.2008.00931.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:14:46Z","timestamp":1697296486000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1797.2008.00931.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1440-1797.2008.00931.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1797.2008.00931.x","archive":["Portico"],"relation":{},"ISSN":["1320-5358","1440-1797"],"issn-type":[{"value":"1320-5358","type":"print"},{"value":"1440-1797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,3]]},"assertion":[{"value":"2008-03-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}